hotspot -WSS

hotspot

author：knowledge 2025-09-06 03:25:55 - browse：93924

How do cancer drugs work? What makes biotech stocks go up? And why are venture capitalists so optimistic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We also discuss the latest news in the life sciences, including the future of Alzheimer’s disease treatment, a multibillion-dollar deal, and the return of the biotech mega-round.

For more on what we cover, here’s STAT’s coverage of the European Society for Medical Oncology meeting; here’s more on Roivant Sciences; here’s the latest on biotech venture capital; here’s more on the latest Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Eight reasons why you should get an updated Covid vaccine

WSS

The FDA weighs the risks of candy

Cancer cells are shown to suck energy source from immune cells

Massive project maps cells in human brain in unprecedented detail

Paying for Covid pills will soon shift to insurers

Life sciences deals on track to hit lowest point since 2017

Hospitals warn Medicare's drug payment fix is ‘unlawful’

focus

hotspot

explore

As demand for Covid shots wanes, Moderna seeks its next success

Senate panel to vote on hospitals, PBMs, prisoner care

Trump demands the U.S. pay no more for drugs than other countries … again

Cassava reveals details — and problems — with Alzheimer's study

Duchenne breakthrough therapy leaves behind pioneering families

European regulators consider appeal over Amylyx ALS drug

As demand for Covid shots wanes, Moderna seeks its next success

Eight reasons why you should get an updated Covid vaccine

Moonlake's readout produced a cash windfall. Risks remain

Medicare to cover more brain scans related to Alzheimer’s drugs

focus

Physician subsidies by hospitals soar in wake of No Surprises Act

Medtronic CEO on promising devices for diabetes, hypertension

STAT Readout Newsletter: Today in biotech, life science news

How should state employee insurance handle Wegovy?

How clinical AI models' predictive power can degrade over time

Testing for cancer recurrence creates a new limbo for patients

explore

hotspot

Wikipedia

entertainment